Common Molecular Features of Human Kidney Transplant Rejection Reflect Mechanistic Sharing Between T Cell-Mediated and Antibody-Mediated Rejection.

被引：0
|
作者：
Venner, J. [1 ,2 ]
Halloran, P. [2 ]
机构：
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Univ Australia, Edmonton, AB, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
207
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [31] Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies
    Halloran, Philip F.
    Reeve, Jeff P.
    Pereira, Andre B.
    Hidalgo, Luis G.
    Farnulski, Konrad S.
    KIDNEY INTERNATIONAL, 2014, 85 (02) : 258 - 264
  • [32] T Cell-Mediated Rejection Becomes Rare in Late Kidney Transplants Despite Persistent Antibody-Mediated Rejection: Emergence of Split Tolerance
    Halloran, P.
    Reeve, J.
    Famulski, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 232 - 232
  • [33] Acute Antibody-mediated Rejection Coexisting With T Cell-mediated Rejection in Pediatric ABO-incompatible Transplantation
    Yanagi, Yusuke
    Sakamoto, Seisuke
    Yamada, Masaki
    Mimori, Koutaro
    Nakao, Toshimasa
    Kodama, Tasuku
    Uchida, Hajime
    Shimizu, Seiichi
    Fukuda, Akinari
    Nakano, Noriyuki
    Haga, Chiduko
    Yoshioka, Takako
    Kasahara, Mureo
    TRANSPLANTATION DIRECT, 2022, 8 (09): : E1359
  • [34] Transcripts That Differentiate T Cell-Mediated from Antibody-Mediated Rejection Are Differentially Regulated in Human Macrophages
    Badr, Dina F.
    Hidalgo, Luis G.
    Famulski, Konrad S.
    Halloran, Philip F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 400 - 400
  • [35] Distinctive Molecular Features of Antibody-Mediated versus T-Cell Mediated Rejection in Facial Transplantation
    Lopdrup, R.
    Win, T.
    Murakami, N.
    Teague, J.
    Chandraker, A.
    Murphy, G.
    Lian, C.
    Bueno, E.
    Pomahac, B.
    Clark, R.
    Riella, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 610 - 610
  • [36] Quantitative Proteome Profiling in T Cell-Mediated Rejection.
    Song, L.
    Zeng, G.
    Liu, P.
    Fang, F.
    Liu, H.
    Xie, X.
    Randhawa, P.
    Xiao, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 594 - 594
  • [37] Lack of Response to Tocilizumab in Kidney Transplants with Chronic Antibody-Mediated Rejection.
    Kumar, D.
    Safavi, F.
    Sandhu, R.
    Halloran, P.
    Yakubu, I.
    Levy, M.
    Moinuddin, I.
    Kimball, P.
    Kamal, L.
    King, A.
    Massey, H.
    Gupta, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 665 - 666
  • [38] Predictors of Response to Belatacept Conversion in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection.
    Kumar, D.
    Winstead, R.
    Iftikhar, H.
    Minniti, R.
    Khorsandi, S.
    Christensen, J.
    Yakubu, I.
    Moinuddin, I.
    Kamal, L.
    Halloran, P.
    Gupta, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 385 - 386
  • [39] DEFECTIVE T REGULATORY CELL RESPONSES IN KIDNEY TRANSPLANT RECIPIENTS DEVELOPING ANTIBODY-MEDIATED REJECTION
    Louis, Kevin
    Macedo, Camila
    Bailly, Elodie
    Randhawa, Parmjeet
    Zeevi, Adriana
    Lefaucheur, Carmen
    Metes, Diana
    TRANSPLANT INTERNATIONAL, 2021, 34 : 36 - 36
  • [40] Identification of Antibodies Reactive to Vimentin in a Rat Kidney Transplant Model of Chronic Antibody-Mediated Rejection.
    Reese, S.
    Wilson, N.
    Ptak, L.
    Sullivan, J.
    Burlingham, W.
    Djamali, A.
    Panzer, S. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 604 - 605
12345